Caracterización clínica y factores asociados a proteinuria en pacientes afrodescendientes de la región Caribe Colombiana
| datacite.rights | http://purl.org/coar/access_right/c_16ec | |
| dc.contributor.advisor | Aroca Martínez, Gustavo | |
| dc.contributor.advisor | Cadena Bonfanti, Andrés | |
| dc.contributor.advisor | González Torres, Henry Joseth | |
| dc.contributor.author | Rodríguez Murgas, Javier Enrique | |
| dc.date.accessioned | 2026-02-04T22:04:53Z | |
| dc.date.available | 2026-02-04T22:04:53Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | La proteinuria es reconocida como un marcador temprano y sensible de daño renal, asociado a una mayor progresión de la enfermedad renal crónica y a un incremento del riesgo cardiovascular. En población afrodescendiente, la presencia de proteinuria adquiere particular relevancia debido a la interacción entre factores clínicos, determinantes sociales, barreras de acceso a los servicios de salud y exposiciones ocupacionales, especialmente en regiones como el Caribe colombiano, donde la evidencia local es limitada y fragmentada. Objetivo: Caracterizar el perfil clínico de los pacientes afrodescendientes de la región Caribe Colombiana y evaluar los factores sociodemográficos, clínicos, ocupacionales y de acceso a los servicios de salud asociados a la presencia de proteinuria durante el periodo 2022–2025. Metodología: Se realizó un estudio observacional, analítico y de corte transversal, incluyendo 1.590 pacientes afrodescendientes adultos de la región Caribe Colombiana. La información fue recolectada a partir de fuentes primarias mediante la aplicación de una encuesta estructurada, complementada con datos de laboratorio para la identificación de proteinuria. Se efectuaron análisis descriptivos y comparativos entre pacientes con y sin proteinuria utilizando pruebas no paramétricas y pruebas de asociación para variables categóricas. Posteriormente, se construyó un modelo de regresión logística multivariada para identificar factores asociados independientes. Se empleó el software R-CRAN, considerando un nivel de significancia estadística de p < 0,05. Resultados: La prevalencia de proteinuria fue del 21%. Los pacientes con proteinuria presentaron una menor tasa de filtrado glomerular y una mayor frecuencia de hipertensión arterial. En el análisis multivariado, la presencia de proteinuria se asoció de manera independiente con hipertensión arterial, deterioro de la función renal, sexo masculino, falta de afiliación al sistema de salud, consumo de antiinflamatorios no esteroideos y exposición ocupacional a fungicidas. Por el contrario, un mejor acceso a los servicios de salud y un mayor consumo de agua se identificaron como factores protectores. Conclusión: La proteinuria en pacientes afrodescendientes del Caribe colombiano es un hallazgo frecuente y se asocia a una interacción compleja de factores clínicos, sociodemográficos, ocupacionales y estructurales. Estos resultados resaltan la necesidad de estrategias de detección temprana, control de comorbilidades y fortalecimiento del acceso a los servicios de salud, con un enfoque diferencial orientado a reducir inequidades en salud renal en esta población. | spa |
| dc.description.abstract | Proteinuria is recognized as an early and sensitive marker of kidney damage, associated with progression of chronic kidney disease and increased cardiovascular risk. In Afro-descendant populations, proteinuria is of particular relevance due to the interaction between clinical factors, social determinants, barriers to healthcare access, and occupational exposures, especially in regions such as the Colombian Caribbean, where local evidence remains limited. Objective: To characterize the clinical profile of Afro-descendant patients in the Colombian Caribbean region and to evaluate the sociodemographic, clinical, occupational, and healthcare access factors associated with the presence of proteinuria during the period 2022–2025. Methods: An observational, analytical, cross-sectional study was conducted including 1,590 adult Afro-descendant patients from the Colombian Caribbean region. Data were collected from primary sources through a structured survey, complemented with laboratory data for the identification of proteinuria. Descriptive and comparative analyses were performed between patients with and without proteinuria using non-parametric tests and association tests for categorical variables. Subsequently, a multivariable logistic regression model was constructed to identify independent associated factors. Statistical analyses were performed using R software, with a significance level set at p < 0.05. Results: The prevalence of proteinuria was 21%. Patients with proteinuria exhibited a lower estimated glomerular filtration rate and a higher prevalence of arterial hypertension. In the multivariable analysis, proteinuria was independently associated with arterial hypertension, impaired kidney function, male sex, lack of health insurance coverage, use of nonsteroidal anti-inflammatory drugs, and occupational exposure to fungicides. In contrast, better access to healthcare services and higher water intake were identified as protective factors. Conclusion: Proteinuria is a frequent finding among Afro-descendant patients in the Colombian Caribbean and is associated with a complex interaction of clinical, sociodemographic, occupational, and structural factors. These findings highlight the need for early detection strategies, improved control of comorbidities, and strengthened access to healthcare services, using a differential approach aimed at reducing inequities in kidney health within this population. | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/17336 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | |
| dc.subject | Proteinuria | spa |
| dc.subject | Enfermedad renal crónica | spa |
| dc.subject | Población afrodescendiente | spa |
| dc.subject | Factores de riesgo | spa |
| dc.subject | Determinantes sociales de la salud | spa |
| dc.subject | Acceso a los servicios de salud | spa |
| dc.subject | Caribe colombiano | spa |
| dc.subject.keywords | Proteinuria | eng |
| dc.subject.keywords | Chronic kidney disease | eng |
| dc.subject.keywords | Afro-descendant population | eng |
| dc.subject.keywords | Risk factors | eng |
| dc.subject.keywords | Social determinants of health | eng |
| dc.subject.keywords | Access to healthcare services | eng |
| dc.subject.keywords | Colombian Caribbean | eng |
| dc.title | Caracterización clínica y factores asociados a proteinuria en pacientes afrodescendientes de la región Caribe Colombiana | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | Sharma S, Hashmi MF, Bhattacharya PT. Hypotension. 2023. | eng |
| dcterms.references | Mercier FJ, Augè M, Hoffmann C, Fischer C, Le Gouez A. Maternal hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiol 2013;79:62–73. | eng |
| dcterms.references | Belzarena SD. [Ephedrine and etilefrine as vasopressor to correct maternal arterial hypotension during elective cesarean section under spinal anesthesia. Comparative study]. Rev Bras Anestesiol 2006;56:223–9. https://doi.org/10.1590/s0034-70942006000300002. | eng |
| dcterms.references | Bolaños-Arboleda D, Fonseca-Ruiz NJ, Socha-García NI, García-Peñuela E, Monsalve-Mejía G. Etilefrina vs. fenilefrina en hipotensión por anestesia espinal para cesárea: ensayo clínico multicéntrico, controlado, aleatorizado y doble ciego. Rev Colomb Anestesiol 2016;44:89–96. https://doi.org/10.1016/j.rca.2016.01.008. | spa |
| dcterms.references | Hasanin AM, Abou Amer A, Hassabelnaby YS, Mostafa M, Abdelnasser A, Amin SM, et al. The use of epinephrine infusion for the prevention of spinal hypotension during Caesarean delivery: A randomized controlled dose-finding trial. Anaesth Crit Care Pain Med 2023;42:101204. https://doi.org/10.1016/j.accpm.2023.101204. | eng |
| dcterms.references | Kamoshita E, Amano K, Kanai Y, Mochizuki J, Ikeda Y, Kikuchi S, et al. Effect of the interval between onset of sustained fetal bradycardia and cesarean delivery on long‐term neonatal neurologic prognosis. Int J Gynecol Obstet 2010;111:23–7. https://doi.org/10.1016/j.ijgo.2010.05.022. | eng |
| dcterms.references | Shiraishi Zapata CJ. Hypotension and bradycardia before spinal anesthesia. Brazilian J Anesthesiol (English Ed 2017;67:535–7. https://doi.org/10.1016/j.bjane.2014.12.008. | eng |
| dcterms.references | Alegre Andrade P, Mamani Ortiz Y, Árnica Gamón A. Norepinephrine and Etilefrin as prevention of maternal hypotension in cesarean section under spinal anesthesia. Rev Científica Cienc Médica 2018;21:68–72. | eng |
| dcterms.references | Vasile F, La Via L, Murabito P, Tigano S, Merola F, Nicosia T, et al. Non- Invasive Monitoring during Caesarean Delivery: Prevalence of Hypotension and Impact on the Newborn. J Clin Med 2023;12. https://doi.org/10.3390/jcm12237295. | eng |
| dcterms.references | Kalra S, Hayaran N. Arrhythmias following spinal anesthesia for cesarean delivery - Is Wenckebach common? J Anaesthesiol Clin Pharmacol 2011;27:541–3. https://doi.org/10.4103/0970-9185.86604. | eng |
| dcterms.references | Bryce RL, Halperin ME, Sinclair JC. Association between indicators of perinatal asphyxia and adverse outcome in the term infant: a methodological review. Neuroepidemiology 1985;4:24–38. https://doi.org/10.1159/000110211. | eng |
| dcterms.references | VanValkinburgh D, Kerndt CC, Hashmi MF. Inotropes and Vasopressors. 2025. | eng |
| dcterms.references | Ng PH, Walters WAW. The Effects of Chronic Maternal Hypotension During Pregnancy. Aust New Zeal J Obstet Gynaecol 1992;32:14–6. https://doi.org/10.1111/j.1479-828X.1992.tb01888.x. | eng |
| dcterms.references | Lim G, Facco FL, Nathan N, Waters JH, Wong CA, Eltzschig HK. A Review of the Impact of Obstetric Anesthesia on Maternal and Neonatal Outcomes. Anesthesiology 2018;129:192–215. https://doi.org/10.1097/ALN.0000000000002182. | eng |
| dcterms.references | Park H-S, Choi W-J. Use of vasopressors to manage spinal anesthesia- induced hypotension during cesarean delivery. Anesth Pain Med 2024;19:85– 93. https://doi.org/10.17085/apm.24037. | eng |
| dcterms.references | Patel S, Ninave S. Postspinal Anesthesia Hypotension in Caesarean Delivery: A Narrative Review. Cureus 2024;16:e59232. https://doi.org/10.7759/cureus.59232. | eng |
| dcterms.references | Melaku L. Physiological Changes in the Pregnancy and Anesthetic Implication during Labor, Delivery, and Postpartum. Open Anesth J 2022;16. https://doi.org/10.2174/25896458-v16-e2207130. | eng |
| dcterms.references | Šklebar I, Bujas T, Habek D. SPINAL ANAESTHESIA-INDUCED HYPOTENSION IN OBSTETRICS: PREVENTION AND THERAPY. Acta Clin Croat 2019;58:90–5. https://doi.org/10.20471/acc.2019.58.s1.13. | eng |
| dcterms.references | Mostafa M, Hassan S, Abdelatef M. How to handle hypotension following spinal anesthesia for a cesarean section. J Curr Med Res Pract 2023;8:57. https://doi.org/10.4103/jcmrp.jcmrp_3_23. | eng |
| dcterms.references | Michelsen TM, Tronstad C, Rosseland LA. Blood pressure and cardiac output during caesarean delivery under spinal anaesthesia: a prospective cohort study. BMJ Open 2021;11:e046102. https://doi.org/10.1136/bmjopen-2020- 046102. | eng |
| dcterms.references | Yu C, Gu J, Liao Z, Feng S. Prediction of spinal anesthesia-induced hypotension during elective cesarean section: a systematic review of prospective observational studies. Int J Obstet Anesth 2021;47:103175. https://doi.org/10.1016/j.ijoa.2021.103175. | eng |
| dcterms.references | Barud AA, Ali IA, Hilowle NM, Hassan HB, Osman IM. Incidence and risk factors of hypotension in cesarean section patients under spinal anesthesia at a referral hospital in Mogadishu, Somalia. BMC Pregnancy Childbirth 2025;25:883. https://doi.org/10.1186/s12884-025-08024-x. | eng |
| dcterms.references | Ferré F, Martin C, Bosch L, Kurrek M, Lairez O, Minville V. Control of Spinal Anesthesia-Induced Hypotension in Adults. Local Reg Anesth 2020;13:39–46. https://doi.org/10.2147/LRA.S240753. | eng |
| dcterms.references | Beatriz Helena Montoya Botero, Clara Inés Oliveros Wilches DAMM. Managing hypotension induced by spinal anesthesia for caesarean section. Rev Colomb Anestesiol 2009;vol.37:6. | eng |
| dcterms.references | Radhitya IGAN, Pratama RA. PREVENTING HYPOTENSION CAUSED BY SPINAL ANESTHESIA IN NON PREECLAPMTIC PREGNANCIES WITH CAESAREAN SECTION. J Sci Heal 2023:190–200. https://doi.org/10.56943/jsh.v2i3.392. | eng |
| dcterms.references | Bower JR, Kinsella SM. Preventing and treating hypotension during spinal anaesthesia for caesarean section. BJA Educ 2020;20:360–1. https://doi.org/10.1016/j.bjae.2020.08.001. | eng |
| dcterms.references | Knigin D, Avidan A, Weiniger CF. The effect of spinal hypotension and anesthesia-to-delivery time interval on neonatal outcomes in planned cesarean delivery. Am J Obstet Gynecol 2020;223:747.e1-747.e13. https://doi.org/10.1016/j.ajog.2020.08.005. | eng |
| dcterms.references | Xu S, Shen X, Liu S, Yang J, Wang X. Efficacy and safety of norepinephrine versus phenylephrine for the management of maternal hypotension during cesarean delivery with spinal anesthesia: A systematic review and meta- analysis. Medicine (Baltimore) 2019;98:e14331. https://doi.org/10.1097/MD.0000000000014331. | eng |
| dcterms.references | Langesæter E, Dyer RA. Maternal haemodynamic changes during spinal anaesthesia for caesarean section. Curr Opin Anaesthesiol 2011;24:242–8. https://doi.org/10.1097/ACO.0b013e32834588c5. | eng |
| dcterms.references | Lee A, Ngan Kee WD, Gin T. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 2002;94:920–6, table of contents. https://doi.org/10.1097/00000539- 200204000-00028. | eng |
| dcterms.references | Ngan Kee WD. Phenylephrine Infusions for Maintaining Blood Pressure During Spinal Anesthesia for Cesarean Delivery. Anesth Analg 2014;118:496– 8. https://doi.org/10.1213/ANE.0000000000000111. | eng |
| dcterms.references | Society for Obstetric Anesthesia and Perinatology. Practice Guidelines for Obstetric Anesthesia. 2016. | eng |
| dcterms.references | Wang Y. Vascular Biology of the Placenta. Colloq Ser Integr Syst Physiol From Mol to Funct 2010;2:1–98. https://doi.org/10.4199/C00016ED1V01Y201008ISP009. | eng |
| dcterms.references | Shafeinia A, Ghaed MA, Nikoubakht N. The Effect of Phenylephrine Infusion on Maternal Hemodynamic Changes During Spinal Anesthesia for Cesarean Delivery. Anesthesiol Pain Med 2020;10:e99094. https://doi.org/10.5812/aapm.99094 | eng |
| dcterms.references | Cho WJ, Cho SY, Lee A-R. Systemic hemodynamic effects of norepinephrine versus phenylephrine in intermittent bolus doses during spinal anesthesia for cesarean delivery. Anesth Pain Med 2020;15:53–60. https://doi.org/10.17085/apm.2020.15.1.53. | eng |
| dcterms.references | Ahmed S, Ahmad E, Fatima E, Akram U, Ur Rehman O, Harikrishna A, et al. Efficacy and safety of norepinephrine versus phenylephrine for post-spinal hypotension in preeclamptic patients: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2024;303:91–8. https://doi.org/10.1016/j.ejogrb.2024.10.012. | eng |
| dcterms.references | Xu C, Liu S, Huang Y, Guo X, Xiao H, Qi D. Phenylephrine vs ephedrine in cesarean delivery under spinal anesthesia: A systematic literature review and meta-analysis. Int J Surg 2018;60:48–59. https://doi.org/10.1016/j.ijsu.2018.10.039. | eng |
| dcterms.references | Royal College of Anaesthetists. Chapter 9 Guidelines for the Provision of Anaesthesia Services (GPAS) Guidelines for the Provision of Anaesthesia Services for an Obstetric Population 2025. 2025. | eng |
| dcterms.references | Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia 2018;73:71–92. https://doi.org/10.1111/anae.14080. | eng |
| dcterms.references | Pratolongo-Perez MP, Vásquez-Yeng JD, Moreno-Gonzales ÁR, López-Vidal RI, Campaña-Acuña AA. Eficacia de la etilefrina y la norepinefrina en la prevención de la hipotensión materna durante la cesárea bajo anestesia espinal: estudio observacional. Rev La Fac Med Humana 2025;25:9. https://doi.org/10.25176/RFMH.v25i1.7296. | spa |
| dcterms.references | Soxhuku-Isufi A, Shpata V, Sula H. Maternal and Neonatal Effects of Vasopressors Used for Treating Hypotension after Spinal Anesthesia for Caesarean Section: A Randomized Controlled Study. Open Access Maced J Med Sci 2016;4:54–8. https://doi.org/10.3889/oamjms.2016.003. | eng |
| dcterms.references | Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR, et al. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. Int J Obstet Anesth 2017;29:18– 25. https://doi.org/10.1016/j.ijoa.2016.08.005. | eng |
| dcterms.references | Heesen M, Hilber N, Rijs K, Rossaint R, Girard T, Mercier FJ, et al. A systematic review of phenylephrine vs. noradrenaline for the management of hypotension associated with neuraxial anaesthesia in women undergoing caesarean section. Anaesthesia 2020;75:800–8. https://doi.org/10.1111/anae.14976. | eng |
| dcterms.references | Ryu C, Choi GJ, Park YH, Kang H. Vasopressors for the management of maternal hypotension during cesarean section under spinal anesthesia: A Systematic review and network meta-analysis protocol. Medicine (Baltimore) 2019;98:e13947. https://doi.org/10.1097/MD.0000000000013947. | eng |
| dcterms.references | Liu P, He H, Zhang S-S, Liang Y, Gao Z-J, Yuan H, et al. Comparative efficacy and safety of prophylactic norepinephrine and phenylephrine in spinal anesthesia for cesarean section: A systematic review and meta-analysis with trial sequential analysis. Front Pharmacol 2022;13:1015325. https://doi.org/10.3389/fphar.2022.1015325. | eng |
| dcterms.references | Singh PM, Singh NP, Reschke M, Ngan Kee WD, Palanisamy A, Monks DT. Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for Caesarean delivery: a Bayesian network meta- analysis of fetal and maternal outcomes. Br J Anaesth 2020;124:e95–107. https://doi.org/10.1016/j.bja.2019.09.045. | eng |
| dcterms.references | Wu W, Zheng Q, Zhou J, Li X, Zhou H. Norepinephrine versus phenylephrine on cerebral tissue oxygen saturation during prophylactic infusion to prevent spinal hypotension for Caesarean birth. Medicine (Baltimore) 2024;103:e37454. https://doi.org/10.1097/MD.0000000000037454. | eng |
| dcterms.references | Zhao S, Chen Q, Qin P, Liu L, Wei K. Comparison of vasopressors for management of hypotension in high-risk caesarean section under neuraxial anesthesia: a systematic review and network meta-analysis. BMC Anesthesiol 2024;24:447. https://doi.org/10.1186/s12871-024-02819-9. | eng |
| dcterms.references | Sun L, Tang Y, Guo F, Liu J, Xu L, Zhu G, et al. Norepinephrine or phenylephrine for the prevention of post-spinal hypotension after caesarean section: A double-blinded, randomized, controlled study of fetal heart rate and fetal cardiac output. J Clin Anesth 2024;97:111533. https://doi.org/10.1016/j.jclinane.2024.111533. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.93 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción:

